1. Korobkin M, White EA, Kressel HY, Moss AA, Montagne JP 1979 Computed tomography in the diagnosis of adrenal disease. AJR Am J Roentgenol 132 (2) : 231-8.

2. Russi S BH 1945 Small adenomas of the adrenal cortex in hypertension and diabetes. Arch Intern Med 76: 284-291.

3. Shamma AH GJ, Sommers SC 1958 A study of the adrenal status in hypertension. J Chron Dis 8:587-595 1958 A study of the adrenal status in hypertension. J Chron Dis 8: 587-595.

4. Commons RR CC 1948 Adenomas of the adrenal cortex. Arch Intern Med 81: 37-41.

5. Hedeland H ÖG, Hökfelt B 1968 On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 184: 211-214.

6. Kokko JP BT, Bermann MM 1967 Adrenal adenoma and hypertension. Lancet 1: 468-470.

7. Chidiac RM, Aron DC 1997 Incidentalomas. A disease of modern technology. Endocrinol Metab Clin North Am 26 (1) : 233-53.

8. Prinz RA, Brooks MH, Churchill R, Graner JL, Lawrence AM, Paloyan E, Sparagana M 1982 Incidental asymptomatic adrenal masses detected by computed tomographic scanning. Is operation required? Jama 248 (6) : 701-4.

9. Allolio B 2001 Adrenal Incidentalomas. In: Margioris AN CG (ed.) Adrenal Disorders, 1 ed. Humana Press Inc., Totowa, pp 249 - 261.

10. Lutz A, Stojkovic M, Schmidt M, Arlt W, Allolio B, Reincke M 2000 Adrenocortical function in patients with macrometastases of the adrenal gland. Eur J Endocrinol 143 (1) : 91-7.

11. Dobbie JW 1969 Adrenocortical nodular hyperplasia: the ageing adrenal. J Pathol 99 (1) : 1-18.

12. Reinhard C SW, Schubert B 1994 Nodules and adenomas in the adrenal cortex: Incidence in post-mortem series and correlation with clinical data. Exp Clin Endocrinol 102 (Suppl 1) : 192.

13. Garz G, Luning M, Melzer B 1985 [Computed tomographic incidental finding of a hormone-inactive adrenal cortex adenoma]. Radiol Diagn 26 (6) : 761-6.

14. Glazer HS, Weyman PJ, Sagel SS, Levitt RG, McClennan BL 1982 Nonfunctioning adrenal masses: incidental discovery on computed tomography. AJR Am J Roentgenol 139 (1) : 81-5.

15. Kley HK WH, Jaresch S, Jungblut R, Schlaghecke R 1990 Endokrin inaktive Nebennierentumoren. In: Allolio B SH (ed.) Moderne Diagnostik und therapeutische Strategien bei Nebennierenerkrankungen. Schattauer, New York, pp 189-197.

16. Stark S PM, Sachse R, Cidlinski K, Riel R, Hahn EG, Dörr HG, Buchfelder M, Hensen J 1994 Endocrine inactive adrenocortical adenomas (ACA) are a condition of the eldery. Exp Clin Endocrinol 102 (Suppl 1) : 193.

17. Kasperlik-Zeluska AA, Roslonowska E, Slowinska-Srzednicka J, Migdalska B, Jeske W, Makowska A, Snochowska H 1997 Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol (Oxf) 46 (1) : 29-37.

18. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A 2000 A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85 (2) : 637-44.

19. Russell RP, Masi AT, Richter ED 1972 Adrenal cortical adenomas and hypertension. A clinical pathologic analysis of 690 cases with matched controls and a review of the literature. Medicine (Baltimore) 51 (3) : 211-25.

20. Reincke M AB 1995 Das Nebenniereninzidentalom: DieKunst der Beschränkung in Diagnostik und Therapie. Dtsch. Ärzteblatt 92: 764-770.

21. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B 1995 Incidentally discovered adrenal masses. Endocr Rev 16 (4) : 460-84.

22. Ross NS, Aron DC 1990 Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med 323 (20) : 1401-5.

23. Latronico AC, Chrousos GP 1997 Extensive personal experience: adrenocortical tumors. J Clin Endocrinol Metab 82 (5) : 1317-24.

24. NIH 2002 Management of the Clinically Inapparent Adrenal Mass ("Incidentaloma") State-of-the-science Conference Statement. National Institute of Health.

25. Neville A 1978 The nodular adrenal. Invest Cell Pathol 1: 99-111.

26. Reincke M, Fassnacht M, Vath S, Mora P, Allolio B 1996 Adrenal incidentalomas: a manifestation of the metabolic syndrome? Endocr Res 22 (4) : 757-61.

27. Toniato A, Merante-Boschin I, Opocher G, Pelizzo MR, Schiavi F, Ballotta E 2009 Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Ann Surg 249 (3) : 388-91.

28. Tsuiki M, Tanabe A, Takagi S, Naruse M, Takano K 2008 Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing's syndrome. Endocr J 55 (4) : 737-45.

29. Sereg M, Szappanos A, Toke J, Karlinger K, Feldman K, Kaszper E, Varga I, Glaz E, Racz K, Toth M 2009 Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study. Eur J Endocrinol 160 (4) : 647-55.

30. Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA, Wieand HS 2003 Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med 138 (5) : 424-9.

31. Bornstein SR, Stratakis CA, Chrousos GP 1999 Adrenocortical tumors: recent advances in basic concepts and clinical management. Ann Intern Med 130 (9) : 759-71.

32. Allolio B, Fassnacht M 2006 Clinical review: Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 91 (6) : 2027-37.

33. Gicquel C, Leblond-Francillard M, Bertagna X, Louvel A, Chapuis Y, Luton JP, Girard F, Le Bouc Y 1994 Clonal analysis of human adrenocortical carcinomas and secreting adenomas. Clin Endocrinol (Oxf) 40 (4) : 465-77.

34. Beuschlein F, Reincke M 2006 Adrenocortical tumorigenesis. Ann N Y Acad Sci 1088: 319-34.

35. Beuschlein F, Reincke M, Karl M, Travis WD, Jaursch-Hancke C, Abdelhamid S, Chrousos GP, Allolio B 1994 Clonal composition of human adrenocortical neoplasms. Cancer Res 54 (18) : 4927-32.

36. Hammwi GJ SR, Kruger FA 1957 Does adrenocortical hyperplasia result in adrenocortical carcinoma? N Engl J Med 257: 1153-1155.

37. Jauresch-Hancke C AB, Metzler U, Bidlingmaier F, Winkelmann W 1988 Adrenocortical carcinoma in a patient with untreated congenital adrenal hyperplasia. Acta Endocrinol 177 (Suppl) (146-147).

38. Jaresch S, Kornely E, Kley HK, Schlaghecke R 1992 Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J Clin Endocrinol Metab 74 (3) : 685-9.

39. Jaresch S SR, Jungblut R, Krüskemper HL, Kley HK 1987 Stumme Nebennierentumoren bei Patienten mit adrenogenitalem Syndrom. Klin Wochschr 65: 627-633.

40. Maser-Gluth C, Reincke M, Allolio B, Schulze E 2000 Metabolism of glucocorticoids and mineralocorticoids in patients with adrenal incidentalomas. Eur J Clin Invest 30 Suppl 3: 83-6.

41. Arnaldi G, Masini AM, Giacchetti G, Taccaliti A, Faloia E, Mantero F 2000 Adrenal incidentaloma. Braz J Med Biol Res 33 (10) : 1177-89.

42. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G 2000 Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 85 (4) : 1440-8.

43. Lacroix A, Tremblay J, Touyz RM, Deng LY, Lariviere R, Cusson JR, Schiffrin EL, Hamet P 1997 Abnormal adrenal and vascular responses to vasopressin mediated by a V1- vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension. J Clin Endocrinol Metab 82 (8) : 2414-22.

44. Lacroix A, Bolte E, Tremblay J, Dupre J, Poitras P, Fournier H, Garon J, Garrel D, Bayard F, Taillefer R, et al. 1992 Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome. N Engl J Med 327 (14) : 974-80.

45. Reznik Y, Allali-Zerah V, Chayvialle JA, Leroyer R, Leymarie P, Travert G, Lebrethon MC, Budi I, Balliere AM, Mahoudeau J 1992 Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med 327 (14) : 981-6.

46. Haidan A, Hilbers U, Bornstein SR, Ehrhart-Bornstein M 1998 Human adrenocortical NCI-H295 cells express VIP receptors. Steroidogenic effect of vasoactive intestinal peptide (VIP). Peptides 19 (9) : 1511-7.

47. Leinonen P, Ranta T, Siegberg R, Pelkonen R, Heikkila P, Kahri A 1991 Testosterone-secreting virilizing adrenal adenoma with human chorionic gonadotrophin receptors and 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 34 (1) : 31-5.

48. Mesiano S, Mellon SH, Jaffe RB 1993 Mitogenic action, regulation, and localization of insulin-like growth factors in the human fetal adrenal gland. J Clin Endocrinol Metab 76 (4) : 968-76.

49. Penhoat A, Chatelain PG, Jaillard C, Saez JM 1988 Characterization of insulin-like growth factor I and insulin receptors on cultured bovine adrenal fasciculata cells. Role of these peptides on adrenal cell function. Endocrinology 122 (6) : 2518-26.

50. Pillion DJ, Arnold P, Yang M, Stockard CR, Grizzle WE 1989 Receptors for insulin and insulin-like growth factor-I in the human adrenal gland. Biochem Biophys Res Commun 165 (1) : 204-11.

51. Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A, Boscaro M 1999 Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 84 (2) : 520-6.

52. Libe R, Dall'Asta C, Barbetta L, Baccarelli A, Beck-Peccoz P, Ambrosi B 2002 Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol 147 (4) : 489-94.

53. Vassilatou E, Vryonidou A, Michalopoulou S, Manolis J, Caratzas J, Phenekos C, Tzavara I 2009 Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study. Clin Endocrinol (Oxf) 70 (5) : 674-9.

54. Terzolo M, Osella G, Ali A, Borretta G, Magro GP, Termine A, Paccotti P, Angeli A 1996 Different patterns of steroid secretion in patients with adrenal incidentaloma. J Clin Endocrinol Metab 81 (2) : 740-4.

55. Hensen J, Buhl M, Bahr V, Oelkers W 1990 Endocrine activity of the "silent" adrenocortical adenoma is uncovered by response to corticotropin-releasing hormone. Klin Wochenschr 68 (12) : 608-14.

56. Reincke M 2000 Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 29 (1) : 43-56.

57. Huiras CM, Pehling GB, Caplan RH 1989 Adrenal insufficiency after operative removal of apparently nonfunctioning adrenal adenomas. Jama 261 (6) : 894-8.

58. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W 1992 Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab 75 (3) : 826-32.

59. Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B 1997 Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome--recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 34 ( Pt 3): 222-9.

60. Nieman LK 2010 Approach to the patient with an adrenal incidentaloma. J Clin Endocrinol Metab 95 (9) : 4106-13.

61. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM 2008 The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93 (5) : 1526-40.

62. Torlontano M, Zingrillo M, D'Aloiso L, Ghiggi MR, Di Cerbo A, Scillitani A, Petracca-Ciavarella G, Liuzzi A 1997 Pre-Cushing's syndrome not recognized by conventional dexamethasone suppression-tests in an adrenal "incidentaloma" patient. J Endocrinol Invest 20 (8) : 501-4.

63. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM, Tischler AS 2007 Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 3 (2) : 92-102.

64. Procopiou M, Finney H, Akker SA, Chew SL, Drake WM, Burrin J, Grossman AB 2009 Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors. Eur J Endocrinol 161 (1) : 131-40.

65. Bravo EL 1994 Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev 15 (3) : 356-68.

66. Calhoun DA 2007 Is there an unrecognized epidemic of primary aldosteronism? Pro. Hypertension 50 (3) : 447-53; discussion 447-53.

67. Schirpenbach C, Reincke M 2007 Primary aldosteronism: current knowledge and controversies in Conn's syndrome. Nat Clin Pract Endocrinol Metab 3 (3) : 220-7.

68. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC 1994 High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21 (4) : 315-8.

69. Gordon RD SA, Stowasser M, Tunny TJ, Storie WJ, Rutherford JC 1993 How common is primary aldosteronism? Is it the most frequent cause of curable hypertension? Journal of Hypertension 11 (Suppl 5) : S310-S311.

70. Mulatero P, Milan A, Fallo F, Regolisti G, Pizzolo F, Fardella C, Mosso L, Marafetti L, Veglio F, Maccario M 2006 Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab 91 (7) : 2618-23.

71. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama T 1981 A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med 141 (12) : 1589-93.

72. Diederich S, Mai K, Bahr V, Helffrich S, Pfeiffer A, Perschel FH 2007 The simultaneous measurement of plasma-aldosterone- and -renin-concentration allows rapid classification of all disorders of the renin-aldosterone system. Exp Clin Endocrinol Diabetes 115 (7) : 433-8.

73. Agharazii M, Douville P, Grose JH, Lebel M 2001 Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension 37 (6) : 1440-3.

74. Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Palumbo G, Rizzoni D, Rossi E, Agabiti-Rosei E, Pessina AC, Mantero F 2007 Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 50 (2) : 424-31.

75. Phillips JL, Walther MM, Pezzullo JC, Rayford W, Choyke PL, Berman AA, Linehan WM, Doppman JL, Gill Jr JR, Jr. 2000 Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 85 (12) : 4526-33.

76. Flecchia D, Mazza E, Carlini M, Blatto A, Olivieri F, Serra G, Camanni F, Messina M 1995 Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour. Clin Endocrinol (Oxf) 42 (2) : 129-34.

77. Osella G, Terzolo M, Borretta G, Magro G, Ali A, Piovesan A, Paccotti P, Angeli A 1994 Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). J Clin Endocrinol Metab 79 (6) : 1532-9.

78. Orentreich N, Brind JL, Rizer RL, Vogelman JH 1984 Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59 (3) : 551-5.

79. Korobkin M, Giordano TJ, Brodeur FJ, Francis IR, Siegelman ES, Quint LE, Dunnick NR, Heiken JP, Wang HH 1996 Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 200 (3) : 743-7.

80. Lee MJ, Hahn PF, Papanicolaou N, Egglin TK, Saini S, Mueller PR, Simeone JF 1991 Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 179 (2) : 415-8.

81. Hamrahian AH, Ioachimescu AG, Remer EM, Motta-Ramirez G, Bogabathina H, Levin HS, Reddy S, Gill IS, Siperstein A, Bravo EL 2005 Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience. J Clin Endocrinol Metab 90 (2) : 871-7.

82. Boland GW, Blake MA, Hahn PF, Mayo-Smith WW 2008 Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology 249 (3) : 756-75.

83. Rezneck RH AP 1994 Imaging in endocrinology. The adrenal gland. Clin Endocrinol 40: 561-576.

84. Heinz-Peer G, Honigschnabl S, Niederle B, Lechner G 1999 [Characterization of adrenal gland space-occupying lesions. Can diagnostic imaging replace biopsy?]. Radiologe 39 (7) : 578-83.

85. Al-Hawary MM, Francis IR, Korobkin M 2005 Non-invasive evaluation of the incidentally detected indeterminate adrenal mass. Best Pract Res Clin Endocrinol Metab 19 (2) : 277-92.

86. Korobkin M, Lombardi TJ, Aisen AM, Francis IR, Quint LE, Dunnick NR, Londy F, Shapiro B, Gross MD, Thompson NW 1995 Characterization of adrenal masses with chemical shift and gadolinium- enhanced MR imaging. Radiology 197 (2) : 411-8.

87. Bardet S, Rohmer V, Murat A, Guillemot C, Marechaud R, Chupin M, Lecomte P, Simon D, Delemer B, Schneebelli S, Beutter D, Jacquin V, Peltier P, Charbonnel B 1996 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas. Clin Endocrinol (Oxf) 44 (5) : 587-96.

88. Barzon L, Scaroni C, Sonino N, Fallo F, Gregianin M, Macri C, Boscaro M 1998 Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J Clin Endocrinol Metab 83 (1) : 55-62.

89. Groussin L, Bonardel G, Silvera S, Tissier F, Coste J, Abiven G, Libe R, Bienvenu M, Alberini JL, Salenave S, Bouchard P, Bertherat J, Dousset B, Legmann P, Richard B, Foehrenbach H, Bertagna X, Tenenbaum F 2009 18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J Clin Endocrinol Metab 94 (5) : 1713-22.

90. Hennings J, Hellman P, Ahlstrom H, Sundin A 2009 Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas. Eur J Radiol 69 (2) : 314-23.

91. Copeland PM 1983 The incidentally discovered adrenal mass. Ann Intern Med 98 (6) : 940-5.

92. Nader S, Hickey RC, Sellin RV, Samaan NA 1983 Adrenal cortical carcinoma. A study of 77 cases. Cancer 52 (4) : 707-11.

93. Yener S, Ertilav S, Secil M, Demir T, Akinci B, Kebapcilar L, Comlekci A, Bayraktar F, Yesil S 2010 Prospective evaluation of tumor size and hormonal status in adrenal incidentalomas. J Endocrinol Invest 33 (1) : 32-6.

94. Cawood TJ, Hunt PJ, O'Shea D, Cole D, Soule S 2009 Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? Eur J Endocrinol 161 (4) : 513-27.

95. Lewinsky BS, Grigor KM, Symington T, Neville AM 1974 The clinical and pathologic features of "non-hormonal" adrenocortical tumors. Report of twenty new cases and review of the literature. Cancer 33 (3) : 778-90.

96. Saeger W, Fassnacht M, Chita R, Prager G, Nies C, Lorenz K, Barlehner E, Simon D, Niederle B, Beuschlein F, Allolio B, Reincke M 2003 High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. Hum Pathol 34 (2) : 180-6.

97. Saeger W FM, Beuschlein F, Prager G, Nies C, Lorenz K, Bärlehner E, Simon D, Niederle B, Allolio B, Reincke M 2001 Ex-vivo biopsies of adrenal lesiona: Morphology of 231 cases. Exp Clin Endocrinol Diabetes 109 (Suppl 1) : S19, v76.

98. Habscheid W, Pfeiffer M, Demmrich J, Muller HA 1990 [Puncture track metastasis after ultrasound-guided fine-needle puncture biopsy. A rare complication?]. Dtsch Med Wochenschr 115 (6) : 212-5.

99. Yankaskas BC, Staab EV, Craven MB, Blatt PM, Sokhandan M, Carney CN 1986 Delayed complications from fine-needle biopsies of solid masses of the abdomen. Invest Radiol 21 (4) : 325-8.

100. Silverman SG, Mueller PR, Pinkney LP, Koenker RM, Seltzer SE 1993 Predictive value of image-guided adrenal biopsy: analysis of results of 101 biopsies. Radiology 187 (3) : 715-8.

101. Quayle FJ, Spitler JA, Pierce RA, Lairmore TC, Moley JF, Brunt LM 2007 Needle biopsy of incidentally discovered adrenal masses is rarely informative and potentially hazardous. Surgery 142 (4) : 497-502; discussion 502-4.

102. Casola G, Nicolet V, vanSonnenberg E, Withers C, Bretagnolle M, Saba RM, Bret PM 1986 Unsuspected pheochromocytoma: risk of blood-pressure alterations during percutaneous adrenal biopsy. Radiology 159 (3) : 733-5.

103. McCorkell SJ, Niles NL 1985 Fine-needle aspiration of catecholamine-producing adrenal masses: a possibly fatal mistake. AJR Am J Roentgenol 145 (1) : 113-4.

104. McLeod MK, Thompson NW, Gross MD, Bondeson AG, Bondeson L 1990 Sub-clinical Cushing's syndrome in patients with adrenal gland incidentalomas. Pitfalls in diagnosis and management. Am Surg 56 (7) : 398-403.

105. Chiodini I, Torlontano M, Carnevale V, Guglielmi G, Cammisa M, Trischitta V, Scillitani A 2001 Bone Loss Rate in Adrenal Incidentalomas: A longitudinal Study. J Clin Endocrinol Metabo 86: 5337-5341.

106. Osella G, Terzolo M, Reimondo G, Piovesan A, Pia A, Termine A, Paccotti P, Angeli A 1997 Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas. J Clin Endocrinol Metab 82 (10) : 3303-7.

107. Sartorio A, Conti A, Ferrero S, Giambona S, Re T, Passini E, Ambrosi B 1998 Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentaloma. Eur J Endocrinol 138 (2) : 146-52.

108. Torlontano M, Chiodini I, Pileri M, Guglielmi G, Cammisa M, Modoni S, Carnevale V, Trischitta V, Scillitani A 1999 Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism. J Clin Endocrinol Metab 84 (7) : 2381-5.

109. Gumbs AA, Gagner M 2006 Laparoscopic adrenalectomy. Best Pract Res Clin Endocrinol Metab 20 (3) : 483-99.

110. de Canniere L, Michel L, Hamoir E, Hubens G, Meurisse M, Squifflet JP, Urbain P, Vereecken L 1997 Multicentric experience of the Belgian Group for Endoscopic Surgery (BGES) with endoscopic adrenalectomy. Surg Endosc 11 (11) : 1065-7.